Trials / Completed
CompletedNCT06444373
Artificial Intelligence in Lung Cancer Screening
Development of an Artificial Intelligence Model in Lung Cancer Screening for the Diagnosis of Lung Nodules and Risk Stratification in Subjects With Occupational and/or Smoking Exposure
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 728 (actual)
- Sponsor
- Scientific Institute San Raffaele · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Accepted
Summary
Single-center, non-profit, observational, retrospective study of collection of clinical and amnestic data and images to create, implement and develop a pilot model of an integrated virtual platform.
Detailed description
The project we propose is a study whose objective was to develop an artificial intelligence program integrated into a web-based platform for the optimization of the performance of lung cancer screening for the diagnosis of lung nodules and risk stratification in subjects exposed to environmental carcinogens and/or cigarette smoke. Inclusion criteria: Age \> 50; smokers for at least 20 pack-years (20 cigarillos a day for 20 years) or former heavy smokers if they quit less than 15 years ago; and/or previous professional exposure to asbestos; absence of lung cancer symptoms; who performed lung cancer screening after the year 2000 upon approval of the study by the relevant EC.
Conditions
Timeline
- Start date
- 2022-12-02
- Primary completion
- 2024-05-22
- Completion
- 2024-05-30
- First posted
- 2024-06-05
- Last updated
- 2024-06-05
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06444373. Inclusion in this directory is not an endorsement.